Premium Nahrungsergänzungsmittel | artgerecht

Pancreatic Secretion – Function, Regulation and Disorders

Pancreatic secretion refers to the release of digestive enzymes and bicarbonate by the pancreas into the small intestine, playing a vital role in the digestion of nutrients.

Regular tips about health Regular tips about health

Things worth knowing about "Pancreatic Secretion"

Pancreatic secretion refers to the release of digestive enzymes and bicarbonate by the pancreas into the small intestine, playing a vital role in the digestion of nutrients.

What Is Pancreatic Secretion?

Pancreatic secretion describes the totality of fluids produced by the pancreas and released into the small intestine (duodenum). This secretion is essential for the digestion of carbohydrates, fats, and proteins. The pancreas has both an exocrine function (releasing secretions into the intestine) and an endocrine function (releasing hormones into the bloodstream). In the context of pancreatic secretion, the exocrine function is of primary importance.

Components of Pancreatic Secretion

Pancreatic secretion consists of two main components:

Enzymatic component: Produced by acinar cells of the pancreas, this component contains a variety of digestive enzymes, including proteases (e.g., trypsinogen, chymotrypsinogen), lipases (e.g., pancreatic lipase), amylases, and nucleases. Many of these enzymes are secreted as inactive precursors (zymogens) to prevent self-digestion of the pancreas.
Aqueous bicarbonate-rich component: Produced by ductal cells, this component contains primarily water, sodium bicarbonate (NaHCO₃), and other electrolytes. The bicarbonate neutralizes the acidic gastric chyme entering the duodenum, creating an optimal pH environment for enzymatic digestion.

Regulation of Pancreatic Secretion

Pancreatic secretion is regulated by both neural and hormonal mechanisms and is divided into three phases:

1. Cephalic Phase

The sight, smell, taste, or even the thought of food triggers secretion via the vagus nerve (parasympathetic nervous system). This phase accounts for approximately 20% of total secretion.

2. Gastric Phase

Distension of the stomach by food and the release of gastrin stimulate the pancreas to increase enzyme production. This phase contributes approximately 5–10% of total secretion.

3. Intestinal Phase

This is the quantitatively most significant phase, accounting for approximately 70–80% of total secretion. When acidic chyme and fatty acids enter the duodenum, two key hormones are released:

Secretin: Released by S-cells in the duodenum, secretin stimulates the production of the bicarbonate-rich aqueous component of pancreatic secretion.
Cholecystokinin (CCK): Released by I-cells in the duodenum and jejunum, CCK promotes the release of digestive enzymes from acinar cells.

Clinical Relevance

Disruptions in pancreatic secretion can lead to serious digestive problems. The most common related conditions include:

Exocrine pancreatic insufficiency (EPI): Insufficient production of digestive enzymes, commonly seen in chronic pancreatitis or cystic fibrosis. Symptoms include fatty stools (steatorrhea), weight loss, and bloating.
Acute pancreatitis: Inflammation of the pancreas in which digestive enzymes are prematurely activated within the organ, causing self-digestion.
Chronic pancreatitis: Long-term inflammation leading to progressive loss of both exocrine and endocrine function.
Pancreatic cancer: A malignant tumor that can obstruct the ductal system and impair secretion.

Diagnosis of Secretory Disorders

Several diagnostic methods are available to assess exocrine pancreatic function:

Fecal elastase-1 measurement: A simple, non-invasive stool test measuring the pancreatic enzyme elastase, used as a screening tool for exocrine insufficiency.
Secretin-pancreozymin test: Considered the gold standard for measuring bicarbonate and enzyme secretion after hormonal stimulation via a duodenal tube.
Imaging: Ultrasound, CT, or MRI to evaluate pancreatic morphology and identify potential structural causes.

Treatment of Pancreatic Secretory Disorders

Exocrine pancreatic insufficiency is primarily treated with pancreatic enzyme replacement therapy (PERT). Enteric-coated capsules containing pancreatic enzymes (lipase, amylase, protease) are taken with meals to compensate for the reduced endogenous production. A tailored diet and supplementation of fat-soluble vitamins (A, D, E, K) are also recommended as part of the overall treatment plan.

References

Herold, G. et al. – Internal Medicine 2023. Self-published, Cologne.
Keller, J. & Layer, P. – Exocrine Pancreatic Insufficiency: Pathophysiology, Diagnosis and Treatment. Deutsches Ärzteblatt, 2005; 102(32–33): A-2178.
Whitcomb, D.C. – Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist. Pancreas, 2022; 51(6): 663–673. PubMed PMID: 35834840.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.